OneThree Biotech

Redesigning drug discovery with biology-driven AI.

[OneThree Biotech @OneThreeBiotech]

OTB joined forces with Poolbeg Pharma plc to discuss the impact that #AI has had in the #pharmaceuticals space! 💊 🔬

Learn about how our platform was used to identify #RSV candidates using AI and our thoughts on current #aitrends 📈

#POLBF #POLB #OTB
https://t.co/AeFiY7Xtb3

[OneThree Biotech @OneThreeBiotech]

Tune in to learn more about how @PoolbegPharma is applying @OneThreeBiotech's ATLANTIS Platform to identify novel drug targets and signatures driving RSV infection!

#collaboration #pharma #biotech #ai #onethreebiotech #polb

[Poolbeg Pharma @PoolbegPharma]

Following our recent #AI announcement, our #CEO & the CEO & co-founder of @OneThreeBiotech,
Neel S. Madhukar discuss...

☑️Significance of this development
❔How the platform works
🤝Overview on collaboration

Tune in:
https://t.co/eYaiquWSjH

#OneThreeBiotech #POLB $POLBF

[OneThree Biotech @OneThreeBiotech]

Very excited to announce a milestone in our partnership with @PoolbegPharma!

OneThree's ATLANTIS Platform enabled Poolbeg to identify novel drug targets and signatures driving RSV infection in under 6 months. This will power the selection of new drug candidates to treat RSV!

[Poolbeg Pharma @PoolbegPharma]

We made a significant breakthrough in our #RSV #ArtificialIntelligence Programme with @OneThreeBiotech

☑️Novel drug targets identified
☑️Final stage can now commence to identify #treatments
☑️ On track for outputs by year end

Learn more:
https://t.co/9aGVTQmXGM

$POLBF #AI

[Neel S. Madhukar @neelmadhukar]

One of our newest approaches at @OneThreeBiotech is early prediction of target-derived tox.

We predicted that PARP1 inhibition is safer than inhibition of PARP2, & I was excited to see this validated independently by an in-vivo study from @AstraZeneca! (https://t.co/62U6NSTyDI)

[Neel S. Madhukar @neelmadhukar]

@lucy_guo Huge shoutout to my co-founder @Coryandar . One of the fastest PhD graduates I know. Worked in a quant hedge fund. And now leads up our AI driven drug discovery efforts at @OneThreeBiotech

[Neel S. Madhukar @neelmadhukar]

Hello science fam! At @OneThreeBiotech we hold a monthly journal club with @ElementoLab and we've been playing around with the idea of hosting them on Clubhouse/twitter spaces to expand community/discussion.

1) what do you guys think? Anyone interested?
2) platform preference?

[Cancer Discovery @CD_AACR]

Check out the #CDturns10 anniversary review on AI in cancer research and precision medicine by @ElementoLab, et al. https://t.co/a5tFUgzqGZ

[Cory Gilvary @Coryandar]

Thrilled to announce this partnership! Having the opportunity to use @OneThreeBiotech's AI approaches to better understand novel biology is exactly why we built this company. https://t.co/L35JEJEhWj

[Neel S. Madhukar @neelmadhukar]

Excited to announce @OneThreeBiotech's recent partnership with Sun Pharma Advanced Research Company (SPARC)!

https://t.co/A3UMp9meRZ

[InHerSight @InHerSight]

Meet @OneThreeBiotech, a biotechnology startup in New York City. Hear from CEO @neelmadhukar on what diversity means, how they're incorporating DEI into their company culture, and what their goals are for the next two years. Plus, explore their benefits!

https://t.co/B40PpHcyI0

[Elizabeth McKenna @ElizSMcKenna]

@BhavneetBhinder, @Coryandar, @neelmahukar, and @ElementoLab discuss the role of #ArtificialIntelligence in cancer research and #precisionmedicine #AI @WeillCornell /13
https://t.co/NznzWSTlqr

[Neel S. Madhukar @neelmadhukar]

Was a pleasure to collaborate with @BhavneetBhinder @ElementoLab @Coryandar @OneThreeBiotech on our recent review: "Artificial Intelligence in Cancer Research and Precision Medicine." Touches on multiple applications of AI in discovery & precision med
https://t.co/wEDEeaZn9X

[OneThree Biotech @OneThreeBiotech]

@CamirRicketts @xtYao @neelmadhukar Give us a few years and that digital business card will be worth millions 😁

[InHerSight @InHerSight]

It's the unwavering positivity for us. @OneThreeBiotech #InternationalWomenDay #IWD2021 #genderequality #march8th https://t.co/vojCTMveIK

[Cory Gilvary @Coryandar]

I always have @OneThreeBiotech with me! (Even on my days off!)

[CellChorus @CellChorus]

Join @_danmeyer (@CellChorus), @andrew_radin (@twoXAR), Brad Pryde (@OneThreeBiotech) & Ben Paice (@_CharltonMorris) in a discussion on artificial intelligence in drug discovery on Thursday December 3rd at 8am Pacific / 11am Eastern / 4pm GMT

#singlecell
https://t.co/4YrWhcQQsv

[Jubilant Therapeutics @JubilantTx]

@JubilantTx is pleased to announce their collaboration with @OneThreeBiotech and the successful completion of a study focused on identifying specific biomarkers for new indications in targeted oncology patient populations. https://t.co/R0gXSNq2wO #biopharma #drugdevelopment

[OneThree Biotech @OneThreeBiotech]

@bradsvrluga @neelmadhukar Proud to have you guys onboard for this journey!

[OneThree Biotech @OneThreeBiotech]

Another example of how biology-driven #AI could advance drug development for patients in need – this time in #melanoma, #MDS, & #AML. We're thrilled to partner with @JubilantTx to pinpoint MoAs & identify new indications for their first in class therapy!

https://t.co/QUCAJL507t

[OneThree Biotech @OneThreeBiotech]

For Breast Cancer Awareness month our Chief Data Scientist @Coryandar walked through how OneThree scientists use our gene interaction module to identify targeted, effective treatments! Here's a video showing an example of BRCA1 synthetic lethal partners: https://t.co/SyZr4GoTSG